$ETON

$53.00▲ +1.6% YTD

5 SEC 13D/G filings tracked · Last updated Nov 2, 2026

Filing History

ETON ▲ +1.6% - Eton Pharmaceuticals, Inc.

CP $53.00▲ +1.6%Nov 2, 2026 · ThinkSabio Blog

$ETON Eton Pharmaceuticals: Launches ET-900 Program for Pediatric Epileptic Spasms, Targets Phase 2 Trial in Q1 2027 ? • Licensing: Secures Baylor Col…

News

ETON ▲ +1.6% - Eton Pharmaceuticals, Inc.

CP $53.00▲ +1.6%Nov 2, 2026 · ThinkSabio Blog

$ETON - Eton Pharmaceuticals Announces Licensing and Initiation of ET-900 Program Evaluating Mecasermin/IGF-1 for Treatment of Infantile and Epileptic…

News

ETON ▲ +0.9% - Eton Pharmaceuticals, Inc.

CP $52.15▲ +0.9%Oct 29, 2026 · ThinkSabio Blog

$ETON - Eton Pharmaceuticals to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026…

News

ETON ▼ -0.4% - Eton Pharmaceuticals, Inc.

CP 62.40▲ -0.4%Aug 27, 2026 · ThinkSabio Blog

$ETON - Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference…

SEC 13D/G

$ETON SEC Filing Update (28-JUL-2026) | ThinkSabio - Stocks Simplified

$47.00▲ 189.41%Jul 28, 2026 · ThinkSabio Blog

$ETON SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #ETON : $47.00 Sector: Healthcare | YTD: 🔼+ 189.41% The SEC disc…